What's Happening in Health: RNA treatment for brain cancer
UC research examines use of microbubbles, RNA for targeted brain tumor treatment
UC scientists are conducting research that could bring hope to those diagnosed with brain cancer.
Daniel Pomeranz Krummel, PhD, research associate professor at UC and author on a new study, was a guest on Local 12's What's Happening in Health, discussing a new RNA treatment being studied for brain tumors.
"We're developing a novel therapeutic approach that will help us treat adult and pediatric brain tumors," he says.
Watch the full interview (Note: Interview starts at around the 5:55 minute mark).
Soma Sengupta, MD, PhD, associate director of the UC Gardner Neuroscience Institute’s Brain Tumor Center, was also involved in this research and was interviewed by WCPO, Channel 9.
Read more about the study on UC News.
Featured photo of a brain courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
RevolutionUC hackathon highlights student ingenuity at 1819
March 14, 2025
The University of Cincinnati’s 1819 Innovation Hub recently hosted three of the Queen City’s premier hackathons: RevolutionUC, MakeUC and UC Startup Weekend.
UC chief digital officer named 2025 Ohio ORBIE Awards Enterprise...
March 14, 2025
University of Cincinnati’s Vice President & Chief Digital Officer Bharath Prabhakaran was named 2025 Ohio ORBIE Awards Enterprise CIO of the Year. This award recognizes Bharath’s leadership in digital transformation, fostering innovation, and enhancing student success at the University of Cincinnati.
UC joins novel bipolar research and clinical care network
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.